Abstract:Cell-intrinsic reporters such as luciferase (LUC) and red fluorescent protein (RFP) have been commonly utilized in preclinical studies to image tumor growth and to monitor therapeutic responses. While extrinsic reporters that emit near infrared I (NIR-I: 650-950 nm) or near-infrared II (NIR-II: 1000 -1700 nm) optical signals have enabled minimization of tissue autofluorescence and light scattering, it has remained unclear as to whether their use has afforded more accurate tumor imaging in small animals. Here, we developed a novel optical imaging construct comprised of rare earth lanthanide nanoparticles coated with biodegradable diblock copolymers and doped with organic fluorophores, generating NIR-I and NIR-II emissive bands upon optical excitation. Simultaneous injection of multiple spectrally-unique nanoparticles into mice bearing tumor implants established via intraperitoneal dissemination of LUC+/ RFP+ OVCAR-8 ovarian cancer cells enabled direct comparisons of imaging with extrinsic vs. intrinsic reporters, NIR-II vs. NIR-I signals, as well as targeted vs. untargeted exogenous contrast agents in the same animal and over time. We discovered that in vivo optical imaging at NIR-II wavelengths facilitates more accurate detection of smaller and earlier tumor deposits, offering enhanced sensitivity, improved spatial contrast, and increased depths of tissue penetration as compared to imaging with visible or NIR-I fluorescent agents. Our work further highlights the hitherto underappreciated enhancements in tumor accumulation that may be achieved with intraperitoneal as opposed to intravenous administration of nanoparticles. Lastly, we found discrepancies in the fidelity of tumor uptake that could be obtained by utilizing small molecules for in vivo as opposed to in vitro targeting of nanoparticles to disseminated tumors. (C) 2017 Elsevier Ltd. All rights reserved.

Molecular-Based FRET Nanosensor with Dynamic Ratiometric NIR-IIb Fluorescence for Real-Time in Vivo Imaging and Sensing

Early Tumor Detection Afforded by in Vivo Imaging of Near-Infrared Ii Fluorescence

NIR-II Dyad-Doped Ratiometric Nanosensor with Enhanced Spectral Fidelity in Biological Media for in Vivo Biosensing

In Vivo Fiber-Optic Fluorescent Sensor for Real-Time Ph Monitoring of Tumor Microenvironment

In Vivo High-resolution Ratiometric Fluorescence Imaging of Inflammation Using NIR-II Nanoprobes with 1550 Nm Emission

Molecular Engineering of Bright NIR-I/NIR-II Nanofluorophores for High-Resolution Bioimaging and Tumor Detection in Vivo.

Long-term monitoring of intravital biological processes using fluorescent protein-assisted NIR-II imaging

NIR‐II Ph Sensor with a FRET Adjustable Transition Point for in Situ Dynamic Tumor Microenvironment Visualization

Fluorescence-amplified nanocrystals in the second near-infrared window for in vivo real-time dynamic multiplexed imaging

A Bright Organic NIR-II Nanofluorophore for Three-Dimensional Imaging into Biological Tissues

NIR-II bioluminescence for in vivo high contrast imaging and in situ ATP-mediated metastases tracing

DNA-enabled rational design of fluorescence-Raman bimodal nanoprobes for cancer imaging and therapy

A Tumor‐Microenvironment‐Responsive Lanthanide–Cyanine FRET Sensor for NIR‐II Luminescence‐Lifetime in Situ Imaging of Hepatocellular Carcinoma

Ratiometric Upconversion Luminescence Nanoprobe With Near-Infrared Ag2s Nanodots As The Energy Acceptor For Sensing And Imaging Of Ph In Vivo

Anti-quenching NIR-II molecular fluorophores for in vivo high-contrast imaging and pH sensing

Er3+ Sensitized 1530 Nm to 1180 Nm Second Near‐Infrared Window Upconversion Nanocrystals for in Vivo Biosensing

Fluorescent Nanosensors Based on Fluorescence Resonance Energy Transfer (FRET)

A FRET-Based Ratiometric H2S Sensor for Sensitive Optical Molecular Imaging in Second Near-Infrared Window

In Vivo Near‐infrared Fluorescence Imaging of Cancer with Nanoparticle‐based Probes

Ph‐activated Near‐Infrared Fluorescence Nanoprobe Imaging Tumors by Sensing the Acidic Microenvironment